Inquire Before Buying - Spinal Muscular Atrophy (SMA) Treatment Market Size & Share Analysis 2030

Global Spinal Muscular Atrophy (SMA) Treatment Market Research Report: Forecast (2025-2030)

Spinal Muscular Atrophy (SMA) Treatment Market Report - By Type (Type I, Type II, Type III, Type IV), By Treatment (Gene Therapy, Disease-Modifying Drugs), By Drug Type (Nusinersen......, Onasemnogene Abeparvovec, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Homecare, Specialty Clinics, Others), and Others Read more

Healthcare
Nov 2024
Pages 189
Report Format: PDF, Excel, PPT

Market Definition

SMA is several related genetic neuromuscular diseases with proximal muscle weakness and atrophy. SMA is characterized by the selective loss of a group of nerve cells in your spinal cord known as lower motor neurons, or anterior horn cells. These co-ordinate muscle contractions or in other words, muscle activity. Without these neurons, muscles do not receive the nerve signals that make muscles contract or move.

Market Insights & Analysis: Global Spinal Muscular Atrophy (SMA) Treatment Market (2025-30):

The Global Spinal Muscular Atrophy (SMA) Treatment Market size was valued at around USD 2.3 billion in 2023 and is projected to reach around USD 30.2 billion by 2030. Along with this, the market is anticipated to grow at a CAGR of around 18.2% during the forecast period, i.e., 2025-30. It is projected that the progress in the Global Spinal Muscular Atrophy (SMA) Treatment Market will be propelled mainly by innovations in gene therapy in addition to the higher focus on research and development of rare genetic disorders. The growing awareness of SMA due to early identification is escalating the demand for SMA treatment.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2023	USD 2.3 Billion
Market Value in 2030	USD 30.2 Billion
CAGR (2025-30)	18.2%
Leading Region	North America
Top Key Players	Biogen, Novartis AG, F. Hoffmann-La Roche Ltd, Cytokinetics, PTC Therapeutics, Inc, Ionis Pharmaceuticals Inc., Astellas Pharma Inc., NMD Pharma A/S, Genzyme Corporation, Genentech, Inc., Pfizer Inc., Scholar Rock Holding Corporation, Novo Nordisk A/S, Takeda Pharmaceutical Co. Ltd, and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, the increasing governmental and healthcare organizations’ participation necessary to fund/subsidize these very expensive treatment programs is further growing the market and also helping in deploying new treatment options. For instance,

August 2024: The Government of India has increased funding for rare diseases, especially Spinal Muscular Atrophy (SMA) allocating nearly USD 10 million this year.

Also, the increasing pipeline of drugs with promising potential, along with the addition of advanced technologies, including gene replacement therapies and antisense oligonucleotide (ASO) treatments, are enhancing the market growth. New disease-modifying therapies (DMTs) are emerging, and the evolving medical facilities in developing economies are opening new opportunities for the pharmaceutical industry for SMA treatment.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Spinal Muscular Atrophy (SMA) Treatment Market Regulations, Policies & Standards
Global Spinal Muscular Atrophy (SMA) Treatment Market Trends & Developments
Global Spinal Muscular Atrophy (SMA) Treatment Market Dynamics
1. Drivers
2. Challenges
Global Spinal Muscular Atrophy (SMA) Treatment Market Hotspots & Opportunities
Global Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
    1. Type I- Market Size & Forecast 2020-2030, USD Million
    2. Type II- Market Size & Forecast 2020-2030, USD Million
    3. Type III- Market Size & Forecast 2020-2030, USD Million
    4. Type IV- Market Size & Forecast 2020-2030, USD Million
  2. By Treatment
    1. Gene Therapy- Market Size & Forecast 2020-2030, USD Million
    2. Disease-Modifying Drugs- Market Size & Forecast 2020-2030, USD Million
  3. By Drug Type
    1. Nusinersen- Market Size & Forecast 2020-2030, USD Million
    2. Onasemnogene Abeparvovec- Market Size & Forecast 2020-2030, USD Million
    3. Others- Market Size & Forecast 2020-2030, USD Million
  4. By Route of Administration
    1. Oral- Market Size & Forecast 2020-2030, USD Million
    2. Injectable- Market Size & Forecast 2020-2030, USD Million
  5. By Distribution Channel
    1. Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
    2. Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
    3. Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
  6. By End User
    1. Hospitals- Market Size & Forecast 2020-2030, USD Million
    2. Homecare- Market Size & Forecast 2020-2030, USD Million
    3. Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
    4. Others- Market Size & Forecast 2020-2030, USD Million
  7. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  8. By Company
    1. Revenue Shares
    2. Competition Characteristics
North America Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2020-2030, USD Million
  2. By Treatment- Market Size & Forecast 2020-2030, USD Million
  3. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  4. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
  5. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  6. By End User- Market Size & Forecast 2020-2030, USD Million
  7. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
4. Canada Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
5. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
South America Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2020-2030, USD Million
  2. By Treatment- Market Size & Forecast 2020-2030, USD Million
  3. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  4. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
  5. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  6. By End User- Market Size & Forecast 2020-2030, USD Million
  7. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
4. Argentina Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
Europe Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2020-2030, USD Million
  2. By Treatment- Market Size & Forecast 2020-2030, USD Million
  3. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  4. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
  5. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  6. By End User- Market Size & Forecast 2020-2030, USD Million
  7. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
4. France Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
5. The UK Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
6. Spain Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
7. Italy Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
The Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2020-2030, USD Million
  2. By Treatment- Market Size & Forecast 2020-2030, USD Million
  3. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  4. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
  5. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  6. By End User- Market Size & Forecast 2020-2030, USD Million
  7. By Country
    1. The UAE
    2. Saudi Arabia
    3. South Africa
    4. Rest of the Middle East & Africa
3. The UAE Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
4. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
5. South Africa Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2020-2030, USD Million
  2. By Treatment- Market Size & Forecast 2020-2030, USD Million
  3. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  4. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
  5. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
  6. By End User- Market Size & Forecast 2020-2030, USD Million
  7. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
4. India Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
5. Japan Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
6. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
7. Australia Spinal Muscular Atrophy (SMA) Treatment Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2020-2030, USD Million
    2. By Treatment- Market Size & Forecast 2020-2030, USD Million
    3. By End User- Market Size & Forecast 2020-2030, USD Million
Global Spinal Muscular Atrophy (SMA) Treatment Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. Biogen
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Novartis AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. F. Hoffmann-La Roche Ltd
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Cytokinetics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. PTC Therapeutics, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Ionis Pharmaceuticals Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Astellas Pharma Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. NMD Pharma A/S
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Genzyme Corporation
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Genentech, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Pfizer Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Scholar Rock Holding Corporation
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Novo Nordisk A/S
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Takeda Pharmaceutical Co. Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *